These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21906458)

  • 1. [Research advances in induced pluripotent stem cells].
    Jiang XR; Lu SX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):456-61. PubMed ID: 21906458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
    Kang L; Kou Z; Zhang Y; Gao S
    J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells: a new technology to study human diseases.
    Vitale AM; Wolvetang E; Mackay-Sim A
    Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cell-derived hepatocytes as an alternative to human adult hepatocytes.
    Katsuda T; Sakai Y; Ochiya T
    J Stem Cells; 2012; 7(1):1-17. PubMed ID: 23550341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells.
    Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K
    J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin microarray analysis of pluripotent and multipotent stem cells.
    Toyoda M; Yamazaki-Inoue M; Itakura Y; Kuno A; Ogawa T; Yamada M; Akutsu H; Takahashi Y; Kanzaki S; Narimatsu H; Hirabayashi J; Umezawa A
    Genes Cells; 2011 Jan; 16(1):1-11. PubMed ID: 21155951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
    Tokumoto Y; Ogawa S; Nagamune T; Miyake J
    J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current progress and prospects of induced pluripotent stem cells.
    Chen L; Liu L
    Sci China C Life Sci; 2009 Jul; 52(7):622-36. PubMed ID: 19641867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ES and iPS cell research for cardiovascular regeneration.
    Yamashita JK
    Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current progress and application prospects of induced pluripotent stem cells].
    Qin T; Miao XY
    Yi Chuan; 2010 Dec; 32(12):1205-14. PubMed ID: 21513145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.
    Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N
    Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.